Table 1:
Serum samples analyzed for CSGV antibodies in the different regional health authorities by age and sex of sample donors
| RHA zone | Age group (in y) and sex
|
Total no. | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10–19
|
20–29
|
30–39
|
40–49
|
50–59
|
60–64
|
||||||||
| M | F | M | F | M | F | M | F | M | F | M | F | ||
| 1 | 9 | 9 | 10 | 10 | 11 | 11 | 12 | 13 | 13 | 13 | 6 | 6 | 123 |
| 2 | 9 | 9 | 8 | 8 | 8 | 9 | 10 | 11 | 11 | 12 | 5 | 5 | 105 |
| 3 | 9 | 8 | 9 | 9 | 9 | 9 | 10 | 11 | 10 | 11 | 5 | 5 | 105 |
| 4 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 2 | 2 | 30 |
| 5 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 16 |
| 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 6 | 3 | 3 | 47 |
| 7 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 1 | 1 | 26 |
| Total no. | 35 | 34 | 35 | 35 | 36 | 38 | 45 | 48 | 49 | 51 | 23 | 23 | 452 |
CSGV= California serogroup viruses; RHA = Regional health authority; M = Male; F = Female